PALVELLA THERAPEUTICS, INC. (PVLA)
About PALVELLA THERAPEUTICS, INC.
Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2023
- $42.8M
- Net income
- -$41.7M
- Total assets
- $59.6M
- Market cap
- $2.0B
- Operating margin
- -1490.4%
- Net margin
- -1610.6%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $2.6M
- Operating expenses
- $38.6M
- Operating income
- -$38.6M
- Income tax
- $0
- Net income
- -$41.7M
- EPS (basic)
- $-3.71
- EPS (diluted)
- $-3.71
Balance sheet
- Total assets
- $59.6M
- Current assets
- $59.0M
- Total liabilities
- $31.6M
- Current liabilities
- $11.3M
- Shareholders’ equity
- $28.0M
Cash flow
- Operating cash flow
- -$25.0M
- Investing cash flow
- $25.6M
- Financing cash flow
- -$660.0K
- Net cash flow
- -$46.0K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $2.0B
- EPS (diluted)
- $-3.71
- Shares outstanding
- 11.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 16, 2024
Palvella Therapeutics, Inc. (PVLA) Stock Price
- Reported a net loss of $41.7M in FY2023.
- Trading 12% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review PALVELLA THERAPEUTICS, INC..
Write a review
News about PALVELLA THERAPEUTICS, INC.
News & sentiment via Polygon.io
Palvella Therapeutics, Inc.: frequently asked questions
Is Palvella Therapeutics, Inc. an American company?
Palvella Therapeutics, Inc. is a US-based company headquartered in Wayne, Pennsylvania, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Palvella Therapeutics, Inc. headquartered?
Palvella Therapeutics, Inc. is headquartered in Wayne, Pennsylvania, United States.
Is Palvella Therapeutics, Inc. publicly traded?
Yes — Palvella Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol PVLA on the NASDAQ.
What does Palvella Therapeutics, Inc. do?
Palvella Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
